Top mesothelioma lawyers
An experimental drug, Cediranib, can benefit according to the results of a clinical trial with patients with rare, slow-growing cancer called alveolar soft part Sarcoma (ASPS).
Mesothelioma lawyers mesothelioma news.Saturday, September 3, 2011
NIH study finds experimental drug benefits patients with rare type of cancer;
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment